Japan Cardiovascular Devices Market Size & Share Analysis - Growth Trends & Forecasts (2025 - 2030)

The Report Covers Japan Cardiovascular Devices Market Outlook & Growth and it is Segmented By Device Type (Diagnostic and Monitoring Devices (Electrocardiogram (ECG), Remote Cardiac Monitoring, and Other Diagnostic and Monitoring Devices) and Therapeutic and Surgical Devices (Cardiac Assist Devices, Cardiac Rhythm Management Devices, Catheter, Grafts, Heart Valves, Stents, and Other Therapeutic and Surgical Devices). The market size and forecasts are provided in terms of value (in USD million) for the above segments.

Japan Cardiovascular Devices Market Size

Japan Cardiovascular Devices Market Summary
View Global Report

Japan Cardiovascular Devices Market Analysis

The Japan Cardiovascular Devices Market is expected to register a CAGR of 3.1% during the forecast period.

COVID-19 has significantly impacted the Japanese cardiovascular devices market due to the decrease in cardiovascular surgeries during the pandemic. According to the NCBI study in January 2021, many departments prohibited cardiological procedures, and the rate of cardiovascular procedures varied according to the pandemic scenario. The decline in procedures during the pandemic restricted the growth of the cardiovascular devices market due to less adoption of these devices. Hence, as the pandemic has subsided, the market is expected to gain traction in the forecast period due to the resumption of cardiovascular surgical procedures after the relaxation of strict regulation on elective surgeries, which will lead to market growth in the post-pandemic era.

The major factors driving the market growth in Japan are the increasing burden of cardiovascular diseases and the increased adoption of minimally invasive procedures.

According to the National Cerebral and Cardiovascular Center, Japan, in December 2021, the number of heart failure patients in Japan was estimated to be approximately 1.2 million. According to the same source, the prevalence rate of cardiovascular diseases increases with age, and the number of heart failure patients is expected to increase further in Japan, where people live to be 100 years old. The high prevalence of heart failure patients in Japan is anticipated to increase the adoption of cardiovascular devices, driving the market growth. 

Furthermore, Japan has the world's fastest-aging population. According to World Data 2022, around 29% of Japan's population was 65 and above in 2021. As the geriatric population is more prone to chronic cardiovascular diseases, the rise in the geriatric population is expected to drive market growth in Japan.

In addition, rising initiatives from the key market players are also expected to drive market growth in Japan due to the rise in the sale of such products. For instance, in March 2022, Rampart IC signed an exclusive distribution agreement with Japan Lifeline (JLL), securing distribution to the Japanese market. The Rampart M1128 is a device developed for interventional cardiologists (ICs) but has found its application in several interventional specialties. Such distribution partnerships will lead to increased adoption of cardiovascular devices in Japan, driving the market growth.

Thus, the rising geriatric population and a high prevalence of heart diseases are expected to show significant growth over the forecast period. However, stringent regulatory policies and the high cost of instruments and procedures are expected to hinder the market growth.

Japan Cardiovascular Devices Industry Overview

The Japanese cardiovascular devices market is moderately fragmented. The factors responsible for the market growth include the rise in technological advancements in the products and increasing advancements from the key market players, among others. Some players currently dominating the market are Abbott Laboratories, Boston Scientific Corporation, Edwards Lifesciences, Medtronic PLC, Cardinal Health Inc., Biotronik, Siemens Healthineers AG, and Canon Medical Systems Corporation.

Japan Cardiovascular Devices Market Leaders

  1. Abbott Laboratories

  2. Boston Scientific Corporation

  3. Cardinal Health Inc

  4. Edwards Lifesciences

  5. Medtronic PLC

  6. *Disclaimer: Major Players sorted in no particular order
Japan Cardiovascular Devices.jpg
Need More Details on Market Players and Competiters?
Download PDF

Japan Cardiovascular Devices Market News

  • October 2022: Japan Lifeline Co., Ltd launched the AT-Patch, a patch-type electrocardiogram (ECG) recorder. The company also announced the execution of a five-year exclusive Japanese distribution agreement for the AT-Patch with IL GANG Medicare Co., Ltd.
  • July 2022: Medtronic PLC entered a strategic partnership with CathWorks, a privately held company, to transform the way coronary artery disease (CAD). As part of the partnership, Medtronic will invest up to USD 75 million and begin co-promotion immediately in Japan and other countries where MathWorks products are sold.

Japan Cardiovascular Devices Market Report - Table of Contents

1. INTRODUCTION

  • 1.1 Study Assumptions & Market Definition
  • 1.2 Scope Of The Study

2. RESEARCH METHODOLOGY

3. EXECUTIVE SUMMARY

4. MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Increasing Burden of Cardiovascular Diseases
    • 4.2.2 Increased Preference of Minimally Invasive Procedures
  • 4.3 Market Restraints
    • 4.3.1 Stringent Regulatory Policies
    • 4.3.2 High Cost of Instruments and Procedures
  • 4.4 Industry Attractiveness - Porter's Five Forces Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5. MARKET SEGMENTATION (Market Size by Value - USD Million)

  • 5.1 By Device Type
    • 5.1.1 Diagnostic and Monitoring Devices
    • 5.1.1.1 Electrocardiogram (ECG)
    • 5.1.1.2 Remote Cardiac Monitoring
    • 5.1.1.3 Other Diagnostic and Monitoring Devices
    • 5.1.2 By Therapeutic and Surgical Devices
    • 5.1.2.1 Cardiac Assist Devices
    • 5.1.2.2 Cardiac Rhythm Management Devices
    • 5.1.2.3 Catheter
    • 5.1.2.4 Grafts
    • 5.1.2.5 Heart Valves
    • 5.1.2.6 Stents
    • 5.1.2.7 Other Therapeutic and Surgical Devices

6. COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 Abbott Laboratories
    • 6.1.2 Boston Scientific Corporation
    • 6.1.3 Cardinal Health Inc.
    • 6.1.4 Medtronic PLC
    • 6.1.5 Edwards Lifesciences
    • 6.1.6 Biotronik
    • 6.1.7 Siemens Healthineers AG
    • 6.1.8 Canon Medical Systems Corporation
  • *List Not Exhaustive

7. MARKET OPPORTUNITIES AND FUTURE TRENDS

**Subject to Availability
**Competitive Landscape covers- Business Overview, Financials, Products and Strategies, and Recent Developments
You Can Purchase Parts Of This Report. Check Out Prices For Specific Sections
Get Price Break-up Now

Japan Cardiovascular Devices Industry Segmentation

Cardiovascular diseases are a group of heart and blood vessel disorders that include coronary heart disease, peripheral arterial disease, congenital heart disease, and cerebrovascular disease. Cardiovascular devices are used to treat or prevent different cardiovascular conditions. 

The Japan Cardiovascular Devices Market is Segmented By Device Type (Diagnostic and Monitoring Devices (Electrocardiogram (ECG), Remote Cardiac Monitoring, and Other Diagnostic and Monitoring Devices) and Therapeutic and Surgical Devices (Cardiac Assist Devices, Cardiac Rhythm Management Devices, Catheter, Grafts, Heart Valves, Stents, and Other Therapeutic and Surgical Devices). The report offers the value (in USD million) for the above segments.

By Device Type Diagnostic and Monitoring Devices Electrocardiogram (ECG)
Remote Cardiac Monitoring
Other Diagnostic and Monitoring Devices
By Therapeutic and Surgical Devices Cardiac Assist Devices
Cardiac Rhythm Management Devices
Catheter
Grafts
Heart Valves
Stents
Other Therapeutic and Surgical Devices
Need A Different Region or Segment?
Customize Now

Japan Cardiovascular Devices Market Research FAQs

What is the current Japan Cardiovascular Devices Market size?

The Japan Cardiovascular Devices Market is projected to register a CAGR of 3.1% during the forecast period (2025-2030)

Who are the key players in Japan Cardiovascular Devices Market?

Abbott Laboratories, Boston Scientific Corporation, Cardinal Health Inc, Edwards Lifesciences and Medtronic PLC are the major companies operating in the Japan Cardiovascular Devices Market.

What years does this Japan Cardiovascular Devices Market cover?

The report covers the Japan Cardiovascular Devices Market historical market size for years: 2021, 2022, 2023 and 2024. The report also forecasts the Japan Cardiovascular Devices Market size for years: 2025, 2026, 2027, 2028, 2029 and 2030.

Japan Cardiovascular Devices Industry Report

Statistics for the 2025 Japan Cardiovascular Devices market share, size and revenue growth rate, created by Mordor Intelligenceā„¢ Industry Reports. Japan Cardiovascular Devices analysis includes a market forecast outlook for 2025 to 2030 and historical overview. Get a sample of this industry analysis as a free report PDF download.

Japan Cardiovascular Devices Market Report Snapshots

Compare market size and growth of Japan Cardiovascular Devices Market with other markets in Healthcare Industry

Japan Cardiovascular Devices Market Size & Share Analysis - Growth Trends & Forecasts (2025 - 2030)